Browsing: Congressional

The bipartisan co-chairs of a congressional psychedelics caucus are touting the Food and Drug Administration’s (FDA) new draft guidance on researching substances like psilocybin and MDMA.…

Bipartisan congressional lawmakers are applauding the Food and Drug Administration (FDA) for releasing first-ever draft guidance on psychedelics research—a development that they had requested through a…

“The fight for cannabis freedom will continue and, given the divided nature of Congress, it will be long.” By: Justin Strekal, BOWL PAC Founder This Fourth…

Bipartisan congressional lawmakers are looking to use a must-pass defense bill as a vehicle to advance a number of drug policy reform proposals, including provisions to…

The federal ban that’s blocked Washington, D.C. from regulating marijuana sales for nearly a decade would be renewed again under a Fiscal Year 2024 spending bill…

The Food and Drug Administration (FDA) has released first-of-its-kind draft guidance on the “unique” considerations that researchers should take into account when studying psychedelics, which the…

A key House committee is calling on Food and Drug Administration (FDA) to “continue and increase” enforcement against CBD companies that make unsanctioned claims about the…

More than a dozen congressional Democrats have filed a resolution to recognize the country’s “moral obligation to meet its foundational promise of guaranteed justice for all,”…

Congressional marijuana reform leaders say that they are encouraged that a top Biden administration official told Marijuana Moment on Thursday that he believes a cannabis scheduling…

Bipartisan congressional lawmakers have filed a new bill to reduce regulations on farmers that grow industrial hemp for non-extraction purposes. Reps. Matt Rosendale (R-MT) and Chrissy…